Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at TRY 994.5B, ahead of Merck & Co (TRY 735B) and Novartis (TRY 577B). Figures as of 19 Nov 2026, 02:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonTRY 994.5B
- Median
- TRY 28.9B
- Combined market value
- TRY 255.28T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | TRY 994.5B | TRY 33.13T | TRY 13,760.77 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | TRY 735B | TRY 17.14T | TRY 6,952.54 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | TRY 577B | TRY 14.79T | TRY 7,832.08 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | TRY 515.2B | TRY 6.14T | TRY 3,005.47 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | TRY 430B | TRY 9.13T | TRY 5,272.19 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | TRY 428.7B | TRY 5.71T | TRY 2,377.73 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | TRY 366.8B | TRY 62.15T | TRY 69,775.22 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | TRY 288.2B | TRY 13.99T | TRY 9,020.44 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | TRY 263.9B | TRY 25.51T | TRY 14,432.41 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | TRY 256.6B | TRY 6.86T | TRY 27,069.91 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | TRY 229.5B | TRY 2.33T | TRY 20,366.14 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | TRY 227.5B | TRY 4.91T | TRY 2,451.41 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | TRY 198.2B | TRY 8.77T | TRY 1,989.69 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | TRY 188.1B | TRY 3.43T | TRY 1,073.31 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 179.4B | TRY 2.49T | TRY 2,130.98 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | TRY 157.3B | TRY 4.94T | TRY 47,712.58 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | TRY 116.7B | TRY 1.75T | TRY 4,317.96 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | TRY 86.5B | TRY 1.59T | TRY 2,572.01 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | TRY 83.6B | TRY 1.01T | TRY 7,538.90 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | TRY 78.6B | TRY 1.24T | TRY 29,133.27 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | TRY 71.6B | TRY 1.42T | TRY 1,954.36 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 70.2B | TRY 802.5B | TRY 12,502.77 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | TRY 66.7B | TRY 1.17T | TRY 1,023.35 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | TRY 66.2B | TRY 600.4B | TRY 3,099.83 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | TRY 57.6B | TRY 8.07T | TRY 1,415.94 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | TRY 49.7B | TRY 253.9B | TRY 3,039.28 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | TRY 46.2B | TRY 290.9B | TRY 427.41 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | TRY 45.5B | TRY 159.1B | TRY 819.99 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | TRY 34.5B | TRY 894.8B | TRY 13,641.18 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | TRY 31.2B | TRY 1.99T | TRY 3,465.17 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | TRY 28.9B | TRY 370.3B | TRY 4,230.16 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | TRY 28.8B | TRY 766.8B | TRY 3,936.48 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | TRY 27.5B | TRY 673.4B | TRY 1,347.31 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | TRY 25.8B | TRY 1.33T | TRY 6,045.25 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | TRY 19.6B | TRY 397.3B | TRY 2,364.11 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | TRY 18.8B | TRY 230.2B | TRY 1,382.13 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | TRY 18B | TRY 430.5B | TRY 15,400.25 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | TRY 17.8B | TRY 320.2B | TRY 7,883.55 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | TRY 16.3B | TRY 355.7B | TRY 6,761.80 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | TRY 15.7B | TRY 244.2B | TRY 1,403.33 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | TRY 15B | TRY 304.7B | TRY 4,667.16 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | TRY 14.2B | TRY 384.7B | TRY 1,104.09 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | TRY 13B | TRY 201.2B | TRY 1,469.43 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 11.4B | TRY 307.5B | TRY 2,175.38 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | TRY 11.4B | TRY 423.7B | TRY 529.84 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 10B | TRY 466.6B | TRY 20,087.59 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | TRY 8.8B | TRY 301.5B | TRY 15,073.27 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 8.4B | TRY 376.9B | TRY 4,796.34 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 8.3B | TRY 630.2B | TRY 755.91 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | TRY 6.5B | TRY 418.8B | TRY 6,416.65 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | TRY 6.2B | TRY 360.7B | TRY 2,589.67 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | TRY 6.1B | TRY 374.4B | TRY 3,420.76 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | TRY 4.7B | TRY 243.4B | TRY 2,535.17 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | TRY 4.3B | TRY 486.2B | TRY 5,119.79 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | TRY 4B | TRY 504.3B | TRY 3,336.49 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | TRY 3.7B | TRY 243.7B | TRY 694.35 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | TRY 3.1B | TRY 228.6B | TRY 2,087.58 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 2.7B | TRY 416.5B | TRY 6,006.90 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | TRY 2.6B | TRY 238.6B | TRY 4,237.73 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | TRY 2.4B | TRY 327.7B | TRY 4,831.16 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | TRY 1.1B | TRY 265.9B | TRY 6,300.59 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4612 TRY).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (TRY 994.5B), Merck & Co (TRY 735B) and Novartis (TRY 577B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 02:23 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of TRY 255.28T as of 19 Nov 2026, 02:23 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.